Your DNA Has “Jumping Genes”. What Do They Have to Do With Ageing?

First: what on earth is a jumping gene?

“Jumping gene” is an informal name for a genetic sequence that can make a copy of itself and insert that copy somewhere else in the genome.

The more technical term is a retrotransposon. You can imagine the genome as an enormous instruction manual. Most of the time, the pages are kept in order. A retrotransposon contains the instructions needed to make an RNA copy and then use that copy to create a new DNA insertion elsewhere in the book.

That does not mean that our DNA is constantly jumping around. Most copies are inactive, incomplete or defective. Cells also have several systems designed to keep potentially active elements switched off.

One important family is called LINE-1, or L1. LINE-1 sequences make up approximately 17% of the human genome. They are ancient components of our DNA, not foreign organisms currently invading us. Their large footprint reflects millions of years of copying and accumulation, not millions of active sequences moving around in every cell.

The useful mental model is not “a parasite is taking over”. It is “the genome contains old mobile machinery that cells usually keep under tight control”.

Why do cells keep them quiet?

Uncontrolled retrotransposition could disrupt the integrity of the genome. A new insertion might interfere with a gene, alter how a nearby gene is regulated or create additional DNA stress. LINE-1 activity can also produce nucleic-acid signals that activate innate immune pathways.

These are plausible ways for loss of control to contribute to cellular dysfunction:

• genomic instability;
• changes in gene regulation;
• DNA damage or replication stress; and
• inflammatory signalling inside the cell.

Genomic instability is one of the features researchers associate with ageing biology. But “associated with ageing biology” is not the same as “the primary cause of human ageing”. Ageing is a network of interacting processes, and the importance of LINE-1 activity can vary between tissues, cell types and experimental models.

That distinction matters because a mechanism can be biologically real without yet being a safe or effective treatment target.

Enter SIRT1

SIRT1 is one member of the sirtuin family of proteins. Researchers have studied sirtuins in metabolism, stress responses, DNA repair, chromatin regulation and ageing biology.

SIRT1 depends on NAD+ for some of its enzymatic activity. That biochemical fact has helped make SIRT1 part of a popular longevity story involving NAD+, NMN, resveratrol, fasting and calorie restriction.

There is a legitimate research question underneath that story: how do metabolism, chromatin and cellular stress responses interact? But a plausible connection is not a supplement recommendation. A molecule can depend on a cellular cofactor without taking more of that cofactor being shown to improve a person’s health.

This new study tested a much narrower question than the marketing version:

Does SIRT1 help keep LINE-1 sequences in a repressed chromatin environment?

What did the new study find?

Wang and colleagues reported in Aging Cell that SIRT1 binds around the 5′ untranslated region of LINE-1 and helps stabilise a group of proteins involved in keeping the surrounding chromatin repressed.

Two of the proteins highlighted were Lamin B1 and KAP1. The researchers linked this arrangement with maintenance of the repressive chromatin mark H3K9me3. In plain English, SIRT1 appeared to help keep the relevant stretch of DNA packed away from the transcription machinery.

In the experimental systems used in the paper:

• SIRT1 overexpression reduced LINE-1 retrotransposition;
• reducing or removing SIRT1 increased LINE-1 transcription and retrotransposition;
• SIRT1 deficiency was associated with genomic instability;
• the cGAS–STING inflammatory-signalling pathway was activated; and
• stress-induced cellular senescence increased.

The researchers also reported that lamivudine, a reverse-transcriptase inhibitor used as a prescription antiviral drug, rescued some of the senescence effect in the experimental model. That is a finding for laboratory research. It does not establish lamivudine as an anti-ageing treatment, and nobody should take it for that purpose.

Does this mean jumping genes are making us old?

Not proven.

There are at least four different statements that can sound similar but mean very different things:

1. A cellular mechanism: SIRT1 can influence chromatin and LINE-1 activity.
2. Experimental senescence: stressed cells can enter a state in which they stop dividing and change their signalling.
3. Organismal ageing: a whole body changes over time through many interacting processes.
4. Human healthspan: people remain healthier, stronger, more independent or less likely to develop disease.

The paper mainly addresses the first two levels. It provides a mechanistic pathway that researchers can investigate. It does not demonstrate that LINE-1 activity is the primary cause of human ageing, that SIRT1 declines in a way that explains every person’s ageing, or that changing this pathway would prevent age-related disease.

Most of the mechanistic experiments were not validated in primary human cells. The senescence model was stress-induced rather than a demonstration of ordinary replicative ageing. There was no human longevity trial, no measurement of extended healthspan and no evidence that people with higher SIRT1 activity live longer because their LINE-1 sequences are quieter.

Does this mean you should take NMN?

The biochemical relationship between NAD+ and SIRT1 is a reason for researchers to study the pathway. It is not a shortcut from “SIRT1 uses NAD+” to “more NAD+ will make people age better”. The missing steps include absorption, tissue distribution, dose, safety, meaningful target engagement and — most importantly — improvement in outcomes that matter to people.

Age-related changes in NAD+ have also been used in supplement marketing as though they automatically prove a clinical deficiency. They do not. A cellular change can be interesting without being a diagnosis, and a proposed mechanism can be interesting without being a treatment.

What about exercise, fasting and calorie restriction?

Exercise, fasting and calorie restriction have all been studied in relation to metabolism, stress signalling, sirtuins and ageing biology. That is a wider research field, not a result of this particular experiment.

This study does not demonstrate that:

• exercise suppresses LINE-1 activity in humans through SIRT1;
• fasting protects your genome by keeping jumping genes switched off; or
• calorie restriction prevents human ageing through this pathway.

Exercise has strong independent evidence for supporting physical function and health. You do not need a LINE-1 mechanism to justify being active. Likewise, a broadly healthy diet and adequate sleep do not need to be repackaged as molecular hacks to be worthwhile.

Don’t major in the minor. A fascinating mechanism should not distract from the fundamentals.

For a wider look at what ageing biomarkers can and cannot tell us, see the Longevity Coach review of rentosertib and biological-age clocks. For practical evidence literacy around a popular nutrient claim, read Do You Actually Need a Magnesium Supplement?.

Why this research still matters

“Not actionable yet” does not mean “not important”. Ageing science increasingly asks how control of the genome deteriorates with age and whether mobile genetic elements contribute to inflammation, senescence or age-related disease.

If those links become clearer, researchers might eventually develop:

• better biomarkers of genomic stress;
• therapeutic targets for specific diseases;
• ways to preserve genomic stability in particular tissues; or
• new approaches to diseases in which retrotransposon activity is relevant.

Those are possibilities, not promises. A useful future treatment would need to affect the right cells, at the right time, without disrupting the many normal roles of chromatin, inflammation and cellular senescence.

The Longevity Coach view

This is exactly the sort of longevity research we want to UNDERSTAND without pretending it is something we can already IMPROVE.

Biological-age research is most useful when it helps scientists compare groups, understand disease or test a future treatment. It is not automatically a personal score. We should not tell members that a molecular pathway has revealed their exact biological age, or that a supplement can repair it.

For now, the Longevity Coach framework stays simple:

• MEASURE: researchers are developing better ways to measure molecular changes associated with ageing.
• UNDERSTAND: SIRT1 may be one part of the machinery helping cells suppress LINE-1 activity and preserve genomic stability.
• IMPROVE: there is no validated Longevity Coach intervention for suppressing jumping genes in healthy people.
• MAINTAIN: keep prioritising established healthspan behaviours rather than chasing an unproven molecular shortcut.

What should I do with this information?

Interesting biology is not automatically actionable health advice

LINE-1 sequences are a remarkable part of the human genome. SIRT1 appears to help keep them quiet in the experimental systems studied by Wang and colleagues. When that control was lost, the cells showed more LINE-1 activity and several signs of genomic and inflammatory stress.

That is a worthwhile discovery. It may help researchers understand how genomic control changes with age and where future treatments might act.

But the evidence has not crossed the distance from a cellular mechanism to human longevity. There was no NMN trial, no human anti-ageing intervention and no demonstration of longer healthspan or lifespan.

Measure. Understand. Improve. Maintain.

Sources / Further reading

• Primary source: Wang X, Li T, Tang H et al. SIRT1 Silences L1 Retrotransposons by Stabilizing Heterochromatin-Modifying Complexes. Aging Cell. First published 30 August 2026. DOI: 10.1111/acel.70689.
• Background review: The role of retrotransposable elements in aging and age-associated diseases. This provides context for LINE-1 biology and the limits of translating retrotransposon mechanisms into human ageing claims.
• Healthspan context: NHS exercise guidance. Exercise remains useful because of its independent evidence for health, not because this paper proves a LINE-1 mechanism.
• Did an AI-Designed Drug Really Make Patients Biologically Younger?
• Do You Actually Need a Magnesium Supplement?
• Don’t Just Move More. Move in More Ways.